Explore more publications!
Technology Post Micronesia
Got News to Share?

Technology Post Micronesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Post Micronesia.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 19, 2025

Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
December 19, 2025

Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial

Indeterminate GlobeNewswire
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
December 19, 2025

Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial

Indeterminate GlobeNewswire
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
December 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Indeterminate GlobeNewswire
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
December 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Indeterminate GlobeNewswire
Virtune is launching Virtune Bittensor ETP on Nasdaq Stockholm
December 19, 2025

Virtune is launching Virtune Bittensor ETP on Nasdaq Stockholm

Indeterminate GlobeNewswire
Virtune lanserar Virtune Bittensor ETP på Nasdaq Stockholm
December 19, 2025

Virtune lanserar Virtune Bittensor ETP på Nasdaq Stockholm

Indeterminate GlobeNewswire
Genenta Science Provides Update on CEO Ownership
December 19, 2025

Genenta Science Provides Update on CEO Ownership

Indeterminate GlobeNewswire
Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)
December 19, 2025

Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)

Indeterminate GlobeNewswire
Ipsen fait le point sur l'essai de Phase II FALKON chez les patients atteints d’une maladie osseuse ultra-rare, la fibrodysplasie ossifiante progressive (FOP)
December 19, 2025

Ipsen fait le point sur l'essai de Phase II FALKON chez les patients atteints d’une maladie osseuse ultra-rare, la fibrodysplasie ossifiante progressive (FOP)

Indeterminate GlobeNewswire
Fushi Technology Partners with Jumbo to Build Long-Term Growth Momentum with One-Stop Customer Loyalty Solution
December 19, 2025

Fushi Technology Partners with Jumbo to Build Long-Term Growth Momentum with One-Stop Customer Loyalty Solution

Indeterminate GlobeNewswire
Gen Art x Finicky Filly Debuts “The Edit”: A Groundbreaking Fashion and Art Retail Experience at Miami’s Iconic National Hotel
December 19, 2025

Gen Art x Finicky Filly Debuts “The Edit”: A Groundbreaking Fashion and Art Retail Experience at Miami’s Iconic National Hotel

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions